RU2013111136A - NON-INVASIVE METHOD OF LASER NANODIAGNOSTICS OF ONCOLOGICAL DISEASES - Google Patents

NON-INVASIVE METHOD OF LASER NANODIAGNOSTICS OF ONCOLOGICAL DISEASES Download PDF

Info

Publication number
RU2013111136A
RU2013111136A RU2013111136/15A RU2013111136A RU2013111136A RU 2013111136 A RU2013111136 A RU 2013111136A RU 2013111136/15 A RU2013111136/15 A RU 2013111136/15A RU 2013111136 A RU2013111136 A RU 2013111136A RU 2013111136 A RU2013111136 A RU 2013111136A
Authority
RU
Russia
Prior art keywords
laser
patient
nanodiagnostics
diagnostic indicator
invasive method
Prior art date
Application number
RU2013111136/15A
Other languages
Russian (ru)
Other versions
RU2542427C2 (en
Inventor
Владимир Генриевич Меледин
Антон Сергеевич Чубов
Игорь Семёнович Кунин
Сергей Владимирович Двойнишников
Юрий Александрович Аникин
Григорий Владимирович Бакакин
Владимир Геннадьевич Главный
Владимир Антонович Павлов
Виталий Владиславович Рахманов
Original Assignee
Федеральное государственное бюджетное учреждение науки Институт теплофизики им. С.С. Кутателадзе Сибирского отделения Российской академии наук (ИТ СО РАН)
Открытое акционерное общество "Институт оптико-электронных информационных технологий" (ОАО "ИОИТ")
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение науки Институт теплофизики им. С.С. Кутателадзе Сибирского отделения Российской академии наук (ИТ СО РАН), Открытое акционерное общество "Институт оптико-электронных информационных технологий" (ОАО "ИОИТ") filed Critical Федеральное государственное бюджетное учреждение науки Институт теплофизики им. С.С. Кутателадзе Сибирского отделения Российской академии наук (ИТ СО РАН)
Priority to RU2013111136/15A priority Critical patent/RU2542427C2/en
Priority to PCT/RU2014/000145 priority patent/WO2014142710A1/en
Priority to EA201500888A priority patent/EA029562B1/en
Publication of RU2013111136A publication Critical patent/RU2013111136A/en
Application granted granted Critical
Publication of RU2542427C2 publication Critical patent/RU2542427C2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/493—Physical analysis of biological material of liquid biological material urine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47—Scattering, i.e. diffuse reflection
    • G01N21/49—Scattering, i.e. diffuse reflection within a body or fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Неинвазивный способ лазерной нанодиагностики онкологических заболеваний заключающийся в исследовании биологической жидкости пациента методом лазерной корреляционной спектроскопии, определении диагностического показателя и диагностировании заболевания по значению диагностического показателя, отличающийся тем, чтов качестве биологической жидкости используют мочу пациента, а диагностический показатель пациента вычисляют как среднеквадратичное отклонение от эталонной частотно-временной флуктуации интенсивности светорассеяния в полосе частот 1-10Гц.A non-invasive method of laser nanodiagnostics of oncological diseases consisting in examining a patient’s biological fluid using laser correlation spectroscopy, determining a diagnostic indicator and diagnosing a disease by the value of a diagnostic indicator, characterized in that the patient’s urine is used as a biological fluid, and the patient’s diagnostic indicator is calculated as the standard deviation from the reference frequency -time fluctuation of light scattering intensity in the frequency band 1-10Hz.

Claims (1)

Неинвазивный способ лазерной нанодиагностики онкологических заболеваний заключающийся в исследовании биологической жидкости пациента методом лазерной корреляционной спектроскопии, определении диагностического показателя и диагностировании заболевания по значению диагностического показателя, отличающийся тем, что в качестве биологической жидкости используют мочу пациента, а диагностический показатель пациента вычисляют как среднеквадратичное отклонение от эталонной частотно-временной флуктуации интенсивности светорассеяния в полосе частот 1-106 Гц. A non-invasive method of laser nanodiagnostics of oncological diseases consisting in the study of the patient’s biological fluid by laser correlation spectroscopy, determination of the diagnostic indicator and diagnosis of the disease by the value of the diagnostic indicator, characterized in that patient’s urine is used as biological fluid, and the patient’s diagnostic indicator is calculated as the standard deviation from the standard time-frequency fluctuation of light scattering intensity in the frequency range 1-106 Hz
RU2013111136/15A 2013-03-12 2013-03-12 Non-invasive laser nano-diagnostic technique for oncologic diseases RU2542427C2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
RU2013111136/15A RU2542427C2 (en) 2013-03-12 2013-03-12 Non-invasive laser nano-diagnostic technique for oncologic diseases
PCT/RU2014/000145 WO2014142710A1 (en) 2013-03-12 2014-03-05 Non-invasive method for laser nanodiagnostics of oncological diseases
EA201500888A EA029562B1 (en) 2013-03-12 2014-03-05 Non-invasive method for laser nano-diagnostics of cancer diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2013111136/15A RU2542427C2 (en) 2013-03-12 2013-03-12 Non-invasive laser nano-diagnostic technique for oncologic diseases

Publications (2)

Publication Number Publication Date
RU2013111136A true RU2013111136A (en) 2014-09-20
RU2542427C2 RU2542427C2 (en) 2015-02-20

Family

ID=51537183

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013111136/15A RU2542427C2 (en) 2013-03-12 2013-03-12 Non-invasive laser nano-diagnostic technique for oncologic diseases

Country Status (3)

Country Link
EA (1) EA029562B1 (en)
RU (1) RU2542427C2 (en)
WO (1) WO2014142710A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2586274C1 (en) * 2014-12-08 2016-06-10 федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Западный государственный медицинский университет имени И.И. Мечникова" Министерства здравоохранения Российской Федерации Method of assessing effectiveness of preventive screening in patients relating to groups of health demographic risk population

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2132635C1 (en) * 1996-09-30 1999-07-10 Алексеев Сергей Григорьевич Method and device for diagnosing oncological diseases
US20080026410A1 (en) * 2004-12-02 2008-01-31 Antonia Vlahou Biomarkers for Bladder Cancer
UA14177U (en) * 2005-09-09 2006-05-15 Ukrainian Scient Res I Of Medi Method for assessing renal homeostasis
WO2011053247A1 (en) * 2009-10-29 2011-05-05 Agency For Science, Technology And Research Method for the detection of an analyte by surface enhanced raman spectroscopy (sers)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2586274C1 (en) * 2014-12-08 2016-06-10 федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Западный государственный медицинский университет имени И.И. Мечникова" Министерства здравоохранения Российской Федерации Method of assessing effectiveness of preventive screening in patients relating to groups of health demographic risk population

Also Published As

Publication number Publication date
EA201500888A1 (en) 2016-03-31
WO2014142710A1 (en) 2014-09-18
EA029562B1 (en) 2018-04-30
RU2542427C2 (en) 2015-02-20

Similar Documents

Publication Publication Date Title
PH12017501253A1 (en) Method and apparatus for the measurement of autonomic function for the diagnosis and validation of patient treatments and outcomes
EA201792497A1 (en) ANTIBODIES TO GITR FOR DIAGNOSIS OF MALIGNANT TUMOR
BR112013010015A2 (en) apparatus and method for noninvasive detection of diseases affecting the structural properties of biological tissues
WO2010083204A3 (en) Noninvasive measurement of flavonoid compounds in biological tissue
EP3751283A3 (en) Blood-based screen for detecting neurological diseases in primary care settings
CY1113403T1 (en) NEW INDUSTRIAL INDICATOR FOR MONITORING THE EVOLUTION OF DISEASES AND ASSESSING THE EFFECTIVENESS OF THERAPIES
EA201890819A1 (en) DEVICE FOR NON-INVASIVE MEASUREMENT OF BLOOD SUGAR LEVEL
EA201700123A1 (en) METHOD FOR PREDICTING A VARIANT OF A MEDICAL PREPARATION FOR THE TREATMENT OF DEPRESSION
RU2013111136A (en) NON-INVASIVE METHOD OF LASER NANODIAGNOSTICS OF ONCOLOGICAL DISEASES
ES2570609T3 (en) Method for testing aminoacylase 1 for in vitro diagnosis of colorectal cancer
GB2556741A (en) Clinical thermometer
BR112018076005A2 (en) isolated monoclonal antibody, method for measuring the level of gamma-glutamyl-l-epsilon-lysine (gel), ex vivo method for monitoring apoptosis, use of a specific monoclonal antibody for gamma-glutamyl-l-epsilon-lysine (gel) ), methods for monitoring the efficacy of apoptosis-inducing treatment, method of treating an unregulated apoptosis-associated disease, apoptosis monitoring kit, sepsis treatment method, and side-flow immunoassay device
PL423634A1 (en) Method for detecting and diagnosing of a course of diabetes
EA201001297A1 (en) METHOD FOR DIAGNOSTICS OF HUMAN MELANOMA ON THE BASIS OF DETERMINING THE EXPRESSION LEVEL PHF10 GENE, DIAGNOSTIC KIT
RU2013126763A (en) METHOD FOR DIAGNOSTIC OF PROGNOSTICALLY DANGEROUS FORMS OF PERIPHERAL RETAIN DETROPHIES
RU2012148001A (en) METHOD FOR DIAGNOSTIC ACTIVITY OF NON-SPECIFIC IMMUNE INFLAMMATION IN OSTEOARTHROSIS IN WOMEN WORKING UNDER CONDITIONS OF PHYSICAL OVERSTRAIN
RU2014109427A (en) METHOD FOR DETERMINING THE MOST EFFECTIVE HYPOTENSIVE DRUG FOR NORMALIZING INTERNAL EYE PRESSURE IN GLAUCOMA
RU2016129388A (en) METHOD FOR DETERMINING ULTRASOUND DOSE IN AGE SURGERY SURGERY
RU2011118127A (en) NON-INVASIVE METHOD FOR DETERMINING THE LEVEL OF ONCOMARKERS OF HUMAN ORGANIC FLUID
RU2015131989A (en) DIAGNOSTIC METHOD, NON-DAMAGING BIOLOGICAL TISSUES
RU2014147170A (en) A method for assessing the quality of medical care in a medical institution
RU2012129472A (en) METHOD FOR DETERMINING PROGRESSION OF CANCER OF ABDOMINAL ORGANS
RU2014114573A (en) METHOD FOR DETERMINING THE METHOD OF EXAMINING PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE
CY1124477T1 (en) BIO-SENSOR AND METHOD FOR THE EARLY DIAGNOSIS OF GLAUCOMA
RU2010128216A (en) METHOD FOR DIAGNOSTIC OF ONCOLOGICAL DISEASE